The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal ctDNA monitoring for post-surgical molecular residual disease in patients with stage I-IIIb melanoma.
 
George Ansstas
Consulting or Advisory Role - Novartis
Research Funding - Novocure
 
Karam Khaddour
No Relationships to Disclose
 
Sumedha Sudhaman
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Travel, Accommodations, Expenses - Natera
 
Karen Lin
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Griffin Budde
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Andrew Poklepovic
Speakers' Bureau - Natera
 
Bently Doonan
Honoraria - Curis
Consulting or Advisory Role - Curis; Immunocore; Pfizer; Replimune
Research Funding - Curis; Merck; Regeneron (Inst)
 
Meghan Mooradian
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Istari Oncology; Regeneron; Xilio Therapeutics
Other Relationship - Aptitude Health; Curio Science; Dava Oncology; OncLive/MJH Life Sciences
 
Ryan Sullivan
Consulting or Advisory Role - BridGene Biosciences; Bristol-Myers Squibb; Marengo Therapeutics; Merck; Novartis; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Georgimmune (Inst); Lilly (Inst); Marengo Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Synthekine (Inst); Viralytics (Inst)
 
Vincent Ma
Honoraria - CAHON; Conquer Cancer, the ASCO Foundation; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Bristol Myers Squibb; Delcath Systems; General Dynamics Information Technology; Immunocore; Incyte; MDoutlook; Partner Therapeutics; Regeneron; Replimune; Targeted Oncology; Teiko.bio
Research Funding - AIQ Solutions (Inst); Astellas Pharma (Inst); C4 Therapeutics (Inst); Fujifilm (Inst); Immuneering (Inst); Immunocore (Inst); Innate Pharma (Inst); Jounce Therapeutics (Inst); Krystal Biotech (Inst); Marengo Therapeutics (Inst); Merck (Inst); Natera (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Seagen (Inst); Top Alliance BioScience (Inst); Y-mAbs Therapeutics (Inst)
Travel, Accommodations, Expenses - CAHON; Delcath Systems; Erasca, Inc; Incyte
 
Jeremy Rosiecki
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Genmab; HSC Acquisition; Regeneron
 
Steven Liu
No Relationships to Disclose
 
Ronald Drengler
Stock and Other Ownership Interests - Natera
 
Daniel Flora
Employment - Medpace
Other Relationship - Bexion
 
Georgia Beasley
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Bristol Myers Squibb; Cardinal Health; Regeneron
Research Funding - Checkmate Pharmaceuticals (Inst); Delcath Systems (Inst); Istari Oncology (Inst); Oncosec (Inst); Replimune (Inst); Skyline Diagnostics (Inst)
 
Kristen Rhodin
No Relationships to Disclose
 
John Hyngstrom
No Relationships to Disclose
 
Elise Brunsgaard
No Relationships to Disclose
 
Minetta Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Alan Tan
Stock and Other Ownership Interests - Adaptimmune; Aprea AB; Bluebird Bio; Editas Medicine; FATE Therapeutics; Fusion Pharmaceuticals; ImmunityBio; Iovance Biotherapeutics; MEI Pharma; natera; RAPT Therapeutics
Honoraria - Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Gilead Sciences; Merck; Myovant Sciences; natera; Seagen
Consulting or Advisory Role - Exelixis; Foundation Medicine; Myovant Sciences
Speakers' Bureau - bristol myers squibb; EMD Serono; Exelixis; Gilead Sciences; Merck; natera